-
About FDA
CVM FOIA Electronic Reading Room
-
Policy Statements
-
-
Administrative Staff Manuals
-
-
Product Approval Information
-
-
Compliance & Enforcement
- Warning Letters
- Advisory Action Letters
- Medicated Feeds
- Ruminant Feed Inspections
- CVM Letter to Feed and Feed Ingredient Manufacturers
- Correspondence - Ivy Animal Health (PDF - 91KB)
- Correspondence - Fort Dodge Animal Health (PDF - 81KB)
- Correspondence - Intervet, Inc (PDF - 80KB)
- Correspondence - Schering-Plough Animal Health Cor (PDF - 77KB)
-
-
Safety & Health
- ADE Reports
- Food and Drug Administration/Center for Veterinary Medicine Report on the Risk from Pentobarbital in Dog Food
CVM’s researchers have concluded that the low levels of exposure to pentobarbital that dogs might receive through pet food is unlikely to cause them any adverse health effects. - Veterinary Medicine Advisory Committee
- FDA Response to Citizen Petition, dated March 9, 1999 (PDF - 436KB)
submitted by the Center for Science in the Public Interest, Docket # 99P-0485, re: subtherapeutic uses of antibiotics in livestock feed - FDA Response to Citizen Petition, dated October 21, 1999 (PDF - 30KB)
re: Posilac® (recombinant bovine growth hormone product) - CVM Letter to Land Grant University Presidents
-
Contact Us
- 240-276-9300
- CVMHomeP@cvm.fda.gov
Center for Veterinary Medicine
Communications Staff (CVM)
Food and Drug Administration
7519 Standish Place
HFV-12
Rockville, MD 20855
-
-
-